Product Code: ETC5359015 | Publication Date: Nov 2023 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 | |
The Iran Buprenorphine Market may undergo a gradual slowdown in growth rates between 2025 and 2029. Although the growth rate starts strong at 7.38% in 2025, it steadily loses momentum, ending at 4.52% by 2029.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Iran Buprenorphine Market Overview |
3.1 Iran Country Macro Economic Indicators |
3.2 Iran Buprenorphine Market Revenues & Volume, 2021 & 2031F |
3.3 Iran Buprenorphine Market - Industry Life Cycle |
3.4 Iran Buprenorphine Market - Porter's Five Forces |
3.5 Iran Buprenorphine Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Iran Buprenorphine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Iran Buprenorphine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Iran Buprenorphine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about opioid addiction and the benefits of buprenorphine treatment. |
4.2.2 Government initiatives to address the opioid crisis and promote the use of buprenorphine. |
4.2.3 Growing demand for addiction treatment services in Iran. |
4.3 Market Restraints |
4.3.1 Regulatory challenges and restrictions on the use of buprenorphine. |
4.3.2 Limited access to healthcare facilities and trained medical professionals for administering buprenorphine treatment. |
5 Iran Buprenorphine Market Trends |
6 Iran Buprenorphine Market Segmentations |
6.1 Iran Buprenorphine Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Iran Buprenorphine Market Revenues & Volume, By Analgesic, 2021-2031F |
6.1.3 Iran Buprenorphine Market Revenues & Volume, By Opioid Antagonist, 2021-2031F |
6.2 Iran Buprenorphine Market, By Route of Administration |
6.2.1 Overview and Analysis | 6.2.2 Iran Buprenorphine Market Revenues & Volume, By Injectables, 2021-2031F |
6.2.3 Iran Buprenorphine Market Revenues & Volume, By Sublingual, 2021-2031F |
6.2.4 Iran Buprenorphine Market Revenues & Volume, By Transdermal Patches, 2021-2031F |
6.3 Iran Buprenorphine Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Iran Buprenorphine Market Revenues & Volume, By Hospital Pharmacies, 2021-2031F |
6.3.3 Iran Buprenorphine Market Revenues & Volume, By Retail Pharmacies, 2021-2031F |
6.3.4 Iran Buprenorphine Market Revenues & Volume, By Online Pharmacies, 2021-2031F |
7 Iran Buprenorphine Market Import-Export Trade Statistics |
7.1 Iran Buprenorphine Market Export to Major Countries |
7.2 Iran Buprenorphine Market Imports from Major Countries |
8 Iran Buprenorphine Market Key Performance Indicators |
8.1 Number of healthcare facilities offering buprenorphine treatment. |
8.2 Percentage of physicians trained and authorized to prescribe buprenorphine. |
8.3 Patient retention rates in buprenorphine treatment programs. |
9 Iran Buprenorphine Market - Opportunity Assessment |
9.1 Iran Buprenorphine Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Iran Buprenorphine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Iran Buprenorphine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Iran Buprenorphine Market - Competitive Landscape |
10.1 Iran Buprenorphine Market Revenue Share, By Companies, 2024 |
10.2 Iran Buprenorphine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |